Archimedes is actively looking to add value to the organisation by acquiring both established pharmaceutical companies and brands throughout Europe. The strategy of growth through acquisition will allow Archimedes to deliver on its objective and create a powerful pan-European commercial framework which will be developed and grown with the launch of additional new products and Archimedes’ own pipeline.